Skip to main content

Clinical Trials for Narcolepsy

Is Staying Awake Your Biggest Problem These Days?

Take Back Your Waking Hours with Narcolepsy Clinical Trials.

Narcolepsy is a chronic neurological disorder that affects the brain’s ability to control sleep-wake cycles. Individuals with narcolepsy experience excessive daytime sleepiness (EDS) and may fall asleep suddenly at any time. Other symptoms can include cataplexy (sudden muscle weakness triggered by emotions), sleep paralysis, and vivid hallucinations. These symptoms often disrupt professional life, education, and personal safety.

Revive Research Institute is conducting clinical trials for narcolepsy to evaluate investigational treatment options. These studies aim to reduce the frequency of sleep attacks, manage cataplexy episodes, and improve the overall alertness and quality of life for participants. By joining a narcolepsy research study, you contribute to the development of next-generation therapies for the sleep community.

To be eligible for narcolepsy clinical trials, participants must:

  • Be 18 years of age or older.
  • Have a documented diagnosis of Narcolepsy (Type 1 or Type 2).

*Additional eligibility criteria may apply.

*Participation in clinical trials for narcolepsy may provide access to expert medical care, regular health monitoring, and investigational therapies at no cost. Health insurance is not required to take part in these studies, and joining a narcolepsy research study may help advance future therapies.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
For more info, please visit Privacy Policy.
Clinical Trials for Narcolepsy Flyer

About the Narcolepsy Clinical Trial

Narcolepsy causes overwhelming daytime drowsiness, sleep attacks, and in many cases, a sudden loss of muscle tone. Because current medications may not work for everyone or can cause unwanted side effects, there is a growing interest in narcolepsy clinical trials in Michigan for those seeking more effective solutions.

Revive Research Institute is conducting research to evaluate the safety and efficacy of investigational treatments. This study aims to discover whether new therapies can better stabilize sleep-wake cycles and provide relief where conventional treatments have fallen short.

Participants who meet eligibility after the screening process and qualify for enrollment will receive study-related care, lab assessments, and the investigational medication at no cost.

*All study procedures, doctor visits, and study-related medications are provided free of charge. Insurance is not required, and participants may be compensated for time and travel.

*To take the next step, complete the form above, and a member of our clinical research team will contact you for a brief pre-screening. You’ll discuss your health history and learn if you qualify for the study.

Get Started: What to Expect

If you qualify for the narcolepsy clinical trial in Michigan, you may have access to promising potential treatment options designed to manage symptoms more effectively through investigational treatment for narcolepsy.

After submitting your information, our research team will contact you for a short pre-screening call. If you meet initial requirements, you will be invited to our research site for a screening visit, where we will review your medical history, perform physical exams, and run lab tests.

Those who qualify will review and sign an informed consent form (ICF), explaining study procedures, potential risks, and benefits. Once enrolled, you will receive investigational treatment and ongoing care from our dedicated research staff.

Our team ensures every participant understands their role and feels supported throughout the study. By participating, you help advance treatment options that could benefit future patients through narcolepsy research study efforts.

Age

18 years or older

Cobdition

Narcolepsy (Type 1 or Type 2)

Location

Michigan

Understanding Narcolepsy

Clinical Trials for Narcolepsy
Common Symptoms:

  • Excessive daytime sleepiness
  • Cataplexy (sudden muscle weakness)
  • Sleep paralysis
  • Hallucinations (vivid dreams while falling asleep)
  • Fragmented nighttime sleep
  • Automatic behaviors (continuing tasks while asleep)

Common Risk Factors:

  • Low levels of hypocretin (orexin) in the brain
  • Autoimmune response
  • Family history
  • Brain injury or trauma

While there is currently no cure for narcolepsy, ongoing clinical trials for narcolepsy are essential for developing treatments that target the root cause of the disorder rather than just masking the symptoms.

Addressing Common Questions

What is narcolepsy?

Narcolepsy is a long-term neurological disorder that interferes with the brain’s ability to regulate sleep and wakefulness, leading to intense sleepiness and sudden sleep episodes.

What is the difference between Type 1 and Type 2 Narcolepsy?

Type 1 Narcolepsy involves cataplexy (muscle weakness) and low levels of the brain chemical hypocretin. Type 2 Narcolepsy involves excessive sleepiness without cataplexy and usually shows normal hypocretin levels.

Why should I consider narcolepsy clinical trials in Michigan?

Participating in a narcolepsy clinical study enrollment allows you to access cutting-edge therapies before they are available to the public, receive care from specialists, and help improve future treatment standards.

Is there a cost to participate?

No. All study-related visits, tests, and medications are provided at no cost to you or your insurance provider. Compensation for time and travel is also typically available.

Close Menu

Revive Research Institute, Inc.

28270 Franklin Road
Southfield, MI
48034

T: 248-564-1485
E: info@rev-research.com